Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder-Reference-Cited by-同舟云学术

Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder

Published:2020-10 Issue:8 Volume:88 Page:649-656
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Attwells Sophia,Setiawan Elaine,Rusjan Pablo M.,Xu Cynthia,Hutton Celeste,Rafiei Dorsa,Varughese Benjamin,Kahn Alan,Kish Stephen J.,Vasdev Neil^ORCID,Houle Sylvain,Meyer Jeffrey H.

Funder

Canadian Institutes of Health Research

Brain and Behavior Foundation

National Institute on Drug Abuse

National Institutes of Health

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference45 articles.

1. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases;Minghetti;J Neuropathol Exp Neurol,2004

2. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms;Block;Nat Rev Neurosci,2007

3. The COX-2/prostanoid signaling cascades in seizure disorders;Rojas;Expert Opin Ther Targets,2019

4. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain;Cosenza-Nashat;Neuropathol Appl Neurobiol,2009

5. Translocator protein-18 kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases;Dupont;Int J Mol Sci,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physically informed deep neural networks for metabolite-corrected plasma input function estimation in dynamic PET imaging;Computer Methods and Programs in Biomedicine;2024-11

2. N-palmitoylethanolamide attenuates negative emotions induced by morphine withdrawal in mice;Neuroscience Letters;2024-10

3. Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression;European Archives of Psychiatry and Clinical Neuroscience;2024-07-08

4. The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders—a double-blind, randomized, placebo-controlled proof-of-concept study;Trials;2024-04-22

5. P2X7 receptor: a potential target for treating comorbid anxiety and depression;Purinergic Signalling;2024-04-20